QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)

Biogen Social Media Sentiment

$233.81
-5.49 (-2.29%)
(As of 01/18/2022 04:00 PM ET)
Add
Compare
Today's Range
$231.37
$238.90
50-Day Range
$223.92
$271.82
52-Week Range
$217.10
$468.55
Volume
1.63 million shs
Average Volume
2.23 million shs
Market Capitalization
$34.35 billion
P/E Ratio
22.88
Dividend Yield
N/A
Beta
0.44

Reddit Posts Over Time



View Trending Reddit Stocks

wallstreetbets Posts Over Time



View Trending WallStreetBets Stocks

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Follows Over Time



View Trending Stocks on MarketBeat

MarketBeat Searches Over Time



Recieve BIIB News and Ratings via Email

Sign-up to receive the latest news and ratings for Biogen and its competitors with MarketBeat's FREE daily newsletter.


Social Media Mentions

Recent Reddit Threads

January 5th, 2022  2:12 PM  |  cloudfj |  wallstreetbets
SAVA on a mission to Pluto 🚀🚀

Listen up APES! Cassava Sciences $SAVA is currently in phase 3 trials for a promising drug for Alzheimer’s called Simufilam. Why is that important? There is no drug that is able to treat Alzheimer’s. Biogen came out with a treatment recently that has been a disaster. Simufilam …

December 31st, 2021  10:07 AM  |  Icy-Extension-4074 |  wallstreetbets
Cassava sciences

Get in before this explodes 40% short interest rate, been driven down by Biogen’s big money, and has a legitimate Alzheimer’s drug that has started phase 3 clinical trials!!! Not only that it doesn’t harm its patients is a pill form and could be the start of some very …

December 30th, 2021  4:34 PM  |  psychotrader00 |  FluentInFinance
Here is a Market Recap for today Thursday, Dec 30, 2021

PsychoMarket Recap - Thursday, December 30, 2021 After starting the day green, stocks closed modestly lower, slipping in the last few hours of the session as market participants digested newly released labor market data and surging coronavirus cases across …

December 30th, 2021  4:33 PM  |  psychotrader00 |  stocks
Here is a Market Recap for today Thursday, Dec 30, 2021. Please enjoy!

PsychoMarket Recap - Thursday, December 30, 2021 After starting the day green, stocks closed modestly lower, slipping in the last few hours of the session as market participants digested newly released labor market data and surging coronavirus cases across …

December 30th, 2021  9:30 AM  |  MrComedy325 |  investing_discussion
Biogen’s Possible Suitor

Shares of Biogen (Nasdaq: BIIB) jumped 9.46% on Wednesday due to news that Samsung BioLogics (KRX: 207940) is in negotiations to buy the biotechnology company, according to a report from Korea Economic Daily. Details: The deal could value Biogen at about $42 billion, …

December 30th, 2021  9:30 AM  |  MrComedy325 |  StocksAndTrading
Biogen’s Possible Suitor

Shares of Biogen (Nasdaq: BIIB) jumped 9.46% on Wednesday due to news that Samsung BioLogics (KRX: 207940) is in negotiations to buy the biotechnology company, according to a report from Korea Economic Daily. Details: The deal could value Biogen at about $42 billion, …

December 29th, 2021  4:34 PM  |  psychotrader00 |  StockMarket
Here is a Market Recap for today Wednesday, Dec 29, 2021. Please enjoy!

PsychoMarket Recap - Wednesday, December 29, 2021 Stocks ended the day mostly flat in a pretty uneventful day as the stock market took a breather from the four-day Santa Claus rally that saw the S&P 500 (SPY) gain roughly 4% in just over a week. With no new economic …

December 29th, 2021  4:33 PM  |  psychotrader00 |  stocks
Here is a Market Recap for today Wednesday, Dec 29, 2021. Please enjoy!

PsychoMarket Recap - Wednesday, December 29, 2021 Stocks ended the day mostly flat in a pretty uneventful day as the stock market took a breather from the four-day Santa Claus rally that saw the S&P 500 (SPY) gain roughly 4% in just over a week. With no new economic …

December 21st, 2021  4:51 PM  |  Healthy-Register3044 |  ValueInvesting
Prove me wrong! BIIB, CVS, TROW, DELL, INTC are all great stocks.

BIIB, CVS, TROW, DELL, INTC are all great stocks.

December 14th, 2021  9:52 AM  |  arktikmaze |  StockMarket
Largest YOLO in WSB history – 8 figure initial bet, read what stock it is and be part of history!

*TLDR: Cassava’s Simufilam is the only treatment ever shown in U.S. clinical trials to actually help Alzheimers cognition over time and it’s desperately needed as 1 in 3 Americans die with dementia and Alz is the sixth leading cause of death. I just bet $25M in Cassava because …

December 4th, 2021  12:51 PM  |  Burnitalldown69 |  wallstreetbets
Big Pharma destroying small cap Biotech SGMO

So, Big Pharma jackasses Biogen, who own a 17% stake (24.4M shares total) in Sangamo ($SGMO), have been dumping small amounts of SGMO shares during thinly traded days. For example, on the Friday after Thanksgiving (half-day of trading) they sold 28,884 …

November 29th, 2021  9:36 AM  |  wrathchild120 |  wallstreetbets
BIIB vs LLY vs RHHBY?

Read about Bio companies that are working on FDA approval for Alzheimers Disease. There is one -- Biogen. The stock did really well after the FDA approval, almost doubled! However, because the price range was super high and insurance companies refused to cover the high …

November 3rd, 2021  1:06 AM  |  OnceGotABlowjobAMA |  wallstreetbets
Anavex Call Options YOLO (Nov 2nd 2021)

Ive had some big wins in my relatively short investing career (including a 54,482% gain, a 36,346% gain, and a 5,218% gain), but Ive never put enough money down to turn those huge %age gains into a 7 figure payout. ​ THAT ENDS TODAY ​ \\Background\\ For …

October 20th, 2021  8:44 AM  |  Kant_sleep13 |  Daytrading
Stock Watch List October 20, 2021

The original Gap Watch List Poster. Trade with the best or lose with the rest! Check the post history. This is a gap list, 2nd-day plays and charts that are not gapping with volume WILL NOT MAKE THIS LIST. Good morning, heres my gap watchlist* Gap Ups: ABT, BABA, …

This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.